Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cocaine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    52 result(s) found for: Cocaine. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2008-001397-32 Sponsor Protocol Number: 2480/2008 Start Date*: 2008-05-14
    Sponsor Name:ASL 5 di PISA-ZONA VALDERA
    Full Title: ARIPIPRAZOLE VERSUS ROPIRINOLE: A PILOT , OPEN-LABEL, PROSPECTIVE, RANDOMISED, CONTROLLED, MULTICENTRIC TRIAL, IN THERAPY WITH ROPIRINOLE OR ARIPIPRAZOLE FOR COCAINE DEPENDENCE
    Medical condition: TERAPY FOR COCAINE DEPENDENCE
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2018-000420-34 Sponsor Protocol Number: CHUB-NAC-Craving Start Date*: 2018-11-27
    Sponsor Name:Centre Hospitalier Universitaire Brugmann
    Full Title: Efficacy of N-acetylcysteine on the craving symptoms of hospitalized patients with cocaine addiction.
    Medical condition: Cocaine addiction
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004873 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004024-11 Sponsor Protocol Number: 60-60600-97-103 Start Date*: 2014-07-23
    Sponsor Name:Academic Psychiatric Center - AMC-UvA
    Full Title: New pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands: A double-blind, placebo-controlled randomized feasibility study of sustained release dexamphetamine
    Medical condition: cocaine dependence (according DSM-IV)
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004873 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2013-002516-27 Sponsor Protocol Number: P121006 Start Date*: 2014-03-06
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004873 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000736-33 Sponsor Protocol Number: CAFQ056X2201 Start Date*: 2017-10-25
    Sponsor Name:Novartis Farmacéutica S.A.
    Full Title: A randomized, subject and investigator blinded, placebo-controlled, parallel group study to investigate whether AFQ056 reduces cocaine use in patients diagnosed with Cocaine Use Disorder (CUD).
    Medical condition: Cocaine Use Disorder according to DSM 5
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000173266 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-000208-41 Sponsor Protocol Number: TV1380-COA-201 Start Date*: 2013-09-17
    Sponsor Name:Teva Pharmaceutical Industries Ltd.
    Full Title: A 12-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Once-Weekly Intra-Muscular Injections of TV-1380 (150 mg/week or 30...
    Medical condition: Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004873 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-002996-16 Sponsor Protocol Number: ANRSSHS155STIMAGO Start Date*: 2014-08-14
    Sponsor Name:Inserm-ANRS
    Full Title: ANRS SHS155 STIMAGO: Pilote study to evaluate the benefits and the risks of methylphenidate for the treatment of cocain dependence.
    Medical condition: Cocaine dependence
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004873 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-012261-61 Sponsor Protocol Number: 2009-4-CC Start Date*: 2009-08-20
    Sponsor Name:Academic Medical Center
    Full Title: Why methylphenidate is not successful in cocaine-dependent ADHD patients: a SPECT study comparing DAT before and after methylphenidate treatment in ADHD patients with and without cocaine dependence
    Medical condition: ADHD with and without substance use disorder (SUD)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10064104 ADHD LLT
    9.1 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-000179-34 Sponsor Protocol Number: P53 Start Date*: 2013-08-28
    Sponsor Name:Maastricht University
    Full Title: More creative on cocaine?
    Medical condition: It is not really a medical condition that is being investigated. The present research proposal has been designed 1) to assess creativity during cocaine intoxication, and 2) to define the potentia...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-000709-26 Sponsor Protocol Number: 50510617 Start Date*: 2022-01-18
    Sponsor Name:Rigshospitalet, Centre of Head and Orthopaedics
    Full Title: Drug test detection 24 hours after nasal administration of cocaine as a local vasoconstrictor prior to nasal intubation
    Medical condition: Residual systemic cocaine after administration as local nasal vasoconstrictor
    Disease: Version SOC Term Classification Code Term Level
    22.0 100000004867 10013685 Drug effect prolonged LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2021-000691-11 Sponsor Protocol Number: 89303200 Start Date*: 2022-01-18
    Sponsor Name:Rigshospitalet
    Full Title: Comparison of the effect of xylometazoline and cocaine on epistaxis when administered as local vasoconstrictors prior to nasal intubation
    Medical condition: Epistaxis upon nasal intubation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-002183-34 Sponsor Protocol Number: TA-CD 10 Start Date*: 2009-02-18
    Sponsor Name:Celtic Pharma Development Services Bermuda, Ltd.
    Full Title: Estudio Doble Ciego, Aleatorizado, Controlado con Placebo, Multicéntrico para evaluar la Eficacia Clínica, Seguridad e Inmunogenicidad de una Vacuna Humana para Cocaína (TA-CD) en el Tratamiento d...
    Medical condition: Tratamiento de la dependencia de cocaína
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-001786-28 Sponsor Protocol Number: 2008-6-CC Start Date*: 2009-08-20
    Sponsor Name:Academical Medical Center
    Full Title: Innovative approaches for cocaine pharmacotherapy using fMRI: The case of varenicline
    Medical condition: cocaine addiction
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-001929-20 Sponsor Protocol Number: TEST-APO Start Date*: 2010-05-18
    Sponsor Name:Servicio de Psiquiatría. Hospital Universitari Vall d’Hebron
    Full Title: EL TEST DE APOMORFINA COMO MARCADOR BIOLÓGICO DE LAS RECAÍDAS EN PACIENTES DEPENDIENTES DE SUSTANCIAS PSICOTROPAS
    Medical condition: Dependencia de alcohol Dependencia de cocaína Dependencia de heroína
    Disease: Version SOC Term Classification Code Term Level
    9 10001590 Alcohol addiction LLT
    9 10009815 Cocaine addiction LLT
    9 10019935 Heroin addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002090-76 Sponsor Protocol Number: CAF-MT Start Date*: 2007-06-14
    Sponsor Name:SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON
    Full Title: Estudio de la eficacia de la cafeína en el tratamiento de mantenimiento de pacientes con dependencia de cocaína
    Medical condition: COCAINE DEPENDENCE
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-010584-16 Sponsor Protocol Number: 2009/001 Start Date*: 2010-10-25
    Sponsor Name:ZonMw
    Full Title: New pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands.
    Medical condition: Crack-cocaine dependence (according to DSM-IV)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001995 Amphetamine and other psychostimulant dependence LLT
    9.1 10001996 Amphetamine and other psychostimulant dependence, continuous use LLT
    9.1 10001997 Amphetamine and other psychostimulant dependence, episodic use LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005538-59 Sponsor Protocol Number: 22-09-2008 Start Date*: 2009-02-18
    Sponsor Name:ZonMw
    Full Title: Impulsivity, a risk factor in relapse to substance use disorder: investigating neural substrates before and after pharmacological challenges
    Medical condition: Alcohol dependence Cocaine dependence
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-002237-11 Sponsor Protocol Number: ARC Start Date*: 2012-12-17
    Sponsor Name:King's College London [...]
    1. King's College London
    2. South London and Maudsley NHS Foundation Trust
    Full Title: Effectiveness of Adaptive Opioid Agonist Maintenance Pharmacotherapy and Behavioural Therapy for Opioid Use Disorder.
    Medical condition: Opiate dependency disorder
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-002249-35 Sponsor Protocol Number: mkjf001 Start Date*: 2006-10-26
    Sponsor Name:Addiction Center Stockholm
    Full Title: Clinical trial of sustained release methylphenidate for Attention-Deficit-Hyperactivity-Disorder (ADHD) in adult criminal offenders with amphetamine addiction
    Medical condition: 54 male prison inmates (27 in each treatment condition) that meet the DSM-IV criteria for amphetamine addiction and for ADHD and who are servicing their prison sentence are recruited.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2013-002584-25 Sponsor Protocol Number: 10/46/01 Start Date*: 2014-11-06
    Sponsor Name:King's College London [...]
    1. King's College London
    2. South London and Maudsley NHS Foundation Trust
    Full Title: Naltrexone Enhanced Addiction Treatment (NEAT): A randomised controlled trial of the clinical and cost-effectiveness of extended-release naltrexone and oral naltrexone.
    Medical condition: Opiate addiction
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004873 10019935 Heroin addiction LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 02 08:47:34 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA